News

Cookie Notification

We use cookies to collect information about how our website is used and to improve the visitor experience. You can change your browser's cookie settings at any time. Please review our privacy policy for more information. OK

Media Contact

Stephen Schultz
VP Investor Relations (U.S.)
T: 917-280-2424 / 401 500 6570
sschultz@gwpharm.com
 

Recent Press Releases

Nov 16, 1999
GW Pharmaceuticals, the company licensed by the UK Home Office to undertake a pharmaceutical research and development programme to develop prescription cannabis-based medicines, has commenced its clinical programme.
Jun 10, 1999
The Canadian Government is considering a proposal from GW Pharmaceuticals to investigate the uses of non-smoked marijuana as a medicine.
Jan 05, 1999
The first harvest of cannabis plants is now underway at GW Pharmaceuticals, the company licensed by the Home Office to conduct a unique pharmaceutical research and development programme into the medicinal uses of ca